ENZYGNOST(R) ANTI-CMV IGG— 510(k) K913910
Substantially EquivalentBehring Diagnostics, Inc.
FDA 510(k) clearance K913910 for ENZYGNOST(R) ANTI-CMV IGG, Substantially Equivalent on 1992-04-28. Applicant: Behring Diagnostics, Inc..
Clearance details
- Applicant
- Behring Diagnostics, Inc.
- Product code
- Code LFZ
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Somerville, NJ, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.